David Hirsch is a venture capital investor at Compound who built his career as one of Google's earliest non-engineering hires, helping scale Google New York from a Starbucks location and leading commercialization teams there. He brings an unusually hands-on, operator-style approach to venture investing, focusing specifically on portfolio support and go-to-market strategy rather than just deal-sourcing, and has built his personal brand around being a day-to-day commercialization partner who asks founders "How can I help you?" in practical revenue and customer targeting discussions.

• Emphasizes the critical role of storytelling and narrative construction for founders. He suggests that entrepreneurs cannot simply focus on product execution; they must actively educate the market and build a compelling vision even before the data is fully certain. For instance, he highlights the difficulty talented people face when stuck between broken current systems and unclear future ones, making the founder's ability to articulate that transition essential.
• Focuses heavily on category-defining frontier technology, specifically within generative AI and autonomous systems. He frequently points to companies reshaping creative industries or transportation infrastructure as examples of where the future is heading. A prime example is his repeated enthusiasm for RunwayML and its potential to redefine storytelling, as well as his support for Wayve's approach to autonomous driving that adapts to new environments without prior mapping.
• Adopts a worldview centered on the power law, acknowledging that venture returns are driven by a very small number of massive outliers. He notes that the world is likely to become increasingly strange, leading to long-tail outcomes that might seem improbable now but will dominate the long term. This perspective influences his reliance on his partners to identify these non-obvious, often weird opportunities rather than safe bets.
• Shows a strong interest in the intersection of biology, technology, and longevity. He engages with concepts regarding personalized healthcare and using innovation to extend human life spans. This includes highlighting discussions on how individuals can take extreme agency over their own health outcomes and utilizing new levers to live longer and healthier lives.
• Values deep collaboration and trust within investment teams, often deferring to the specific expertise of his partners on complex theses. He indicates that successful venture investing involves giving talented colleagues the space to lead on their convictions. For example, he explicitly mentions stepping back to let his partner Michael Dempsey drive the strategy on financial products and future-facing themes.